Second Malignant Neoplasms following Hematopoietic Stem Cell Transplantation

ArticleinInternational Journal of Hematology 79(3):229-34 · May 2004with4 Reads
Impact Factor: 1.92 · DOI: 10.1532/IJH97.03178 · Source: PubMed

    Abstract

    Hematopoietic stem cell transplantation is being successfully used to treat a variety of malignant and nonmalignant disorders. This therapy has resulted in an increasing number of survivors who are at risk for adverse long-term outcomes, including the development of second and subsequent malignant neoplasms. We review the incidence and spectrum of posttransplantation malignancies and discuss risk factors and future directions for research.